# Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

> **NCT00882193** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Nebraska** · enrollment: 2 (actual)

## Conditions studied

- Chronic Hepatitis C
- Genotype 1
- Relapse

## Interventions

- **DRUG:** Betaine
- **DRUG:** Peginterferon alpha 2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00882193
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05-01
- **Primary completion:** 2011-01-12
- **Final completion:** 2011-01-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** new medications with improved response released
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882193, "Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00882193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*